Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, which in less than half of cases is manifested by hypokalemia. In cases where hypokalemia becomes signifi cant, it can lead to muscle weakness or even paralysis. Such patients are often unsuccessfully treated by neurologists or rheumatologists. In our clinical case a 61 year old patient had rapidly developing symptoms, which were interpreted by ambulance paramedics as an acute cerebrovascular accident. Since the patient was admitted to a multidisciplinary hospital, he was examined by doctors of different specialties, the diagnostic direction was set correctly and rhabdomyolysis was already detected at the initial stage. We excluded various causes of myopathy, which ultimately led us to the most likely cause of this condition -hypokalemia, and explained muscle symptoms. As a result, it helped us to identify the correct diagnosis -aldosteronism. The patient quickly recovered due to the prescribed therapy and felt good, and therefore refused surgical treatment (adrenalectomy), which, perhaps, would allow him to fully recover. Thus, a rare clinical case of differential diagnosis and successful drug treatment of PA with hypokalemia, which is manifested by rhabdomyolysis, is presented.
Introduction
Primary aldosteronism (PA) (Conn's syndrome) is a clinical syndrome caused by excess aldosterone production by zona glomerulosa of the adrenal cortex, which leads to low renin hypertension [1] . PA is the most common reason of high blood pressure among all secondary hypertensions and, according to various sources, occurs from 6% in the general population of patients with arterial hypertension to 20% among patients wth uncontrolled arterial hypertension [2] [3] [4] [5] . Excess aldosterone leads to development of hypernatremia, hypokalemia and metabolic alkalosis. This determines the manifestation of three main clinical syndromes of PA, among which the most constant is arterial hypertension (in 98% of cases) as well as nephro-(50-70%) and myopathy (38-75%). Hypokalemia (less than 3,5 mmol/L), previously considered a mandatory PA symptom, is found in 30-40% of patients with this pathology and likely observed in the most severe cases, according to modern concepts [6] [7] [8] . Hypokalemia-associated myopathy manifests mainly in the form of muscle weakness, however, in rare cases it may result in rhabdomyolysis, as previously reported in a few publications mainly in foreign literature [9] [10] [11] [12] [13] [14] . In view of this, patients can be observed by a neurologist or rheumatologist for a long time before they get the attention of a cardiologist or endocrinologist. The presented clinical case demonstrates the manifestation of PA in the form of hypokalemic rhabdomyolysis.
The clinical case
A 61 year old male was transported by an ambulance team to the hospital with a suspected acute cerebrovascular accident (CVA) with complaints on restriction of movement and weakness in the upper and lower limbs, dizziness and headache. The patient was examined by a neurologist, and underwent computed tomography (CT) scan of the head, no focal brain ischemia was detected. In the neurological status, the © 2019 Konstantin Skaletsky. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivs license (http://creativecommons.org/licenses/by-nc-nd/3.0/). absence of focal symptoms was noteworthy and limitation of limb movement was caused by severe pain in muscles. The patient had a long history of arterial hypertension with a maximum increase in ABP to 220/120mmHg. and the usual ABP of 170/105mmHg, the three-component background therapy consisted of perindopril arginine 10mg, indapamide 2.5mg and bisoprolol 10mg. The patient had been noticing muscle weakness for several weeks, but he only noted the appearance of pain in the limbs with a gradual progression up to the inability to climb several stair steps three days before seeking medical help. The admission electrocardiogram (ECG) revealed changes in repolarisation in the form of ST segment depression up to 2 mm in inferior leads, and the presence of a U-wave ( Figure 1 ). In laboratory analysis hypokalemia of 2.08mmol/l, a pronounced increase in creatine phosphokinase (CPK) up to 11307U/l, increased transaminases, proteinuria, and very alkaline urine (detailed laboratory data is presented in Table 1 ). The patient was consulted by a rheumatologist about myopathic syndrome, dermatomyositis was suspected, however, an immunoblot test did not reveal any autoantibodies. Further diagnostic research included the following most common causes of rhabdomyolysis: direct injuries of striated muscles, prolonged intense exercise, neuromuscular diseases, toxic effects (alcohol, several medicines, snake poison, etc.), infections, hyperthermia and hypokalaemia. With a detailed history taking and additional instrumental examination, all of these conditions were sequentially excluded, except for persistently preserved hypokalaemia at a level of 2.0-2.5mmol/l despite active infusion therapy with potassium. Given the long history of uncontrolled hypertension, hypokalaemia, myopathic syndrome, kidney damage and urinary alkalosis, hyperaldosteronism was suspected.
A blood test for renin and aldosterone revealed high plasma concentration of aldosterone (32.8ng/dl) with the background of a pronounced suppression of renin secretion (0.006ng/dl), which, according to the updated international recommendations of the Endocrine Society (2016) [6] , is a suffi cient criterion for establishing PA as a diagnosis without determining the aldosterone/renin ratio and conducting confi rmatory tests. According to the algorithm, the next step is topical diagnosis, for which the patient underwent adrenal CT with contrast. Masses of both adrenal glands of approximately the same density were revealed: sized 13x17mm in the lateral branch of the left adrenal gland ( Figure 2 ) and 12x9mm in the body of the right adrenal gland (Figure 3 ). During the ongoing background therapy aimed at compensating for the loss of potassium, the patient noted a signifi cant improvement in well-being due to the disappearance of muscle symptoms, so he refused surgery. Based on this, comparative selective adrenal vein sampling (AVS) was not done, since it would not change the tactics of medical treatment. Spironolactone was titrated up to 300 mg per day for the patient in combination with perindopril and bisoprolol. Against this background, the maximum level of potassium during the hospitalisation was 3.1mmol/l. The concentration of CPK gradually decreased. The average blood pressure before discharge was 135-140/80mmHg. Signs of severe hypokalaemia on the ECG were levelled (Figure 4 ). The fi nal diagnosis was stated as follows: "Secondary arterial hypertension (primary aldosteronism complicated by hypokalemic rhabdomyolysis)". Unfortunately, the connection with the patient was lost after discharge and the long-term results of treatment remain unknown. Figure 2 . Mass in the left adrenal gland Figure 3 . Mass in the right adrenal gland active. Unfortunately, CT has a number of limitations: small aldosteromas can be interpreted as diffuse hyperplasia with bilateral or multiple nodular lesions or not be detected at all due to the small size, and "obvious" microadenomas may turn out to be areas of focal hyperplasia and a diagnostic error in this case leads to unreasonable unilateral adrenalectomy [6] . The CT results often do not correspond to the lateralization of aldosterone production in AVS. There are described cases when the aldosteroma assumed by the CT results turned out to be a hormonally inactive adenoma, in contrast to the contralateral "unchanged" adrenal gland [17] . The capabilities of 11C-metomidate positron emission tomography-CT (PET-CT) allow lateralisation with comparable sensitivity and specifi city without resorting to invasive AVS, which is often uninformative due to the technical complexity of this manipulation [18] . However, PET-CT remains an inaccessible diagnostic method due to its high cost. Genetic typing of subtypes and sporadic forms of PA is also practically inaccessible, and the clinical value of determining such mutations remains unclear [8] .
In the case of choosing a medical treatment strategy, the patient should be prescribed the minimum effective dose of spironolactone to reduce the risk of side effects, antiandrogenic activity in particular. Certainly, our patient needed to continue titration of the dosage of spironolactone. However, due to the loss of contact, it was not possible to track down. Better informing of specialists (cardiologists, family physicians, neurologists, rheumatologists, endocrinologists) about the features of this nosology should help ensure that
Discussion
In most cases, PA is manifested by non-specifi c symptoms, and therefore it is often at the junction of various specialties and may remain undetected for a long time. Even hypokalaemia is not always alarming for doctors, although it can be the key to the diagnosis. In our case, we described a rare situation when rhabdomyolysis was the leading symptom of PA. Therefore, we consider it important to screen patients with a combination of hypokalaemia and other unexplained causes of rhabdomyolysis for PA. The mechanism of rhabdomyolysis with hypokalaemia remains debatable, but in general it has quite convincing pathophysiological justifi cations. According to one theory, hypokalaemia leads to dysfunction of the sodium-potassium pump, which causes an increase in cellular permeability to sodium, and the launch of a compensatory sodium-calcium pump. As a result, excess intracellular calcium activates proteolytic enzymes that destroy myocytes [15] . According to another theory, hypokalaemia contributes to inadequate vasodilation of arterioles and capillaries in the muscles with an increased exercise and a decrease in blood fl ow, which leads to ischemia and necrosis of muscle cells [14, 16] . The absence of hyperkalaemia and acute renal failure in this situation, intrinsic to traumatic rhabdomyolysis, is probably caused by permanent increased excretion of potassium and the slow process of destruction of myocytes. Due to the fact that the diagnostic research was completed without performing AVS, the PA subtype remained unclassifi ed by us and it is unclear whether both masses are hormonally 
Conclusion
This clinical example reports a rare manifestation of primary aldosteronism in the form of rhabdomyolysis. The correct diagnosis, established according to the modern algorithm, will successfully treat arterial hypertension and muscle symptoms in such patients, thereby improving both the quality of life and, probably, the prognosis.
